Haoxi Health Technology Holds Annual General Meeting
Ticker: HAO · Form: 6-K · Filed: Jan 14, 2025 · CIK: 1954594
| Field | Detail |
|---|---|
| Company | Haoxi Health Technology LTD (HAO) |
| Form Type | 6-K |
| Filed Date | Jan 14, 2025 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $20,000, $0.0001, $0.0025, $200,000, $1,000,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-meeting
TL;DR
Haoxi Health Tech held its shareholder meeting Jan 10, 2025.
AI Summary
Haoxi Health Technology Limited held its annual general meeting (AGM) on January 10, 2025, both online and in person at its Beijing office. The meeting was conducted in accordance with the Company's Articles of Association and the laws of the Cayman Islands.
Why It Matters
This filing confirms the company held its required annual shareholder meeting, a standard corporate governance event.
Risk Assessment
Risk Level: low — This is a routine corporate filing confirming a shareholder meeting, with no new financial or operational information.
Key Players & Entities
- Haoxi Health Technology Limited (company) — The company holding the meeting
- January 10, 2025 (date) — Date of the annual general meeting
- Beijing, China (location) — Location of the in-person meeting and company headquarters
FAQ
What was the purpose of the January 10, 2025 meeting?
The meeting was the annual general meeting (AGM) of shareholders for Haoxi Health Technology Limited.
Where was the AGM held?
The AGM was held online at www.virtualshareholdermeeting.com/HAO2025 and in person at Room 801, Tower C, Floor 8, Building 103, Huizhongli, Chaoyang District, Beijing, China.
What time did the AGM commence?
The AGM commenced at 10:00 a.m. Eastern Time.
Under what jurisdiction is Haoxi Health Technology Limited incorporated?
The company is incorporated under the laws of the Cayman Islands.
Does Haoxi Health Technology file annual reports under Form 20-F?
Yes, the registrant indicates it files annual reports under cover of Form 20-F.
Filing Stats: 1,166 words · 5 min read · ~4 pages · Grade level 15 · Accepted 2025-01-14 16:15:02
Key Financial Figures
- $20,000 — tion, the authorized share capital of US$20,000 divided into: (i) 150,000,000 Class A O
- $0.0001 — ass A Ordinary Shares of par value of US$0.0001 each, and (ii) 50,000,000 Class B Ordin
- $0.0025 — ass A Ordinary Shares of par value of US$0.0025 each, and (ii) 2,000,000 Class B Ordina
- $200,000 — ital of the Company be increased from US$200,000 divided into (i) 6,000,000 Class A Ordi
- $1,000,000 — res of par value of US$0.0025 each to US$1,000,000 divided into (i) 300,000,000 Class A or
Filing Documents
- ea0227588-6k_haoxi.htm (6-K) — 34KB
- 0001213900-25-003419.txt ( ) — 35KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Haoxi Health Technology Limited Date: January 14, 2025 By: /s/ Zhen Fan Name: Zhen Fan Title: Chief Executive Officer 3